Praxis Precision Medicines logo
Praxis Precision Medicines PRAX
$ 76.99 5.7%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Praxis Precision Medicines Income Statement 2011-2024 | PRAX

Annual Income Statement Praxis Precision Medicines

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

359 M 13.4 M 836 M 1.87 B - - - - - - - - -

Shares

6.59 M 3.07 M 42.5 M 36.7 M - - - - - - - - -

Historical Prices

54.4 4.37 19.7 55 - - - - - - - - -

Net Income

-26.9 M -41.2 M -58.6 M -61.8 M -35.5 M -26.5 M - - - - - - -

Revenue

2.45 M - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-126 M -215 M -167 M -62 M -35.8 M - - - - - - - -

Interest Expense

3.1 M 957 K - - - - - - - - - - -

EBITDA

-126 M -215 M -167 M -61.9 M -35.8 M -22.7 M - - - - - - -

Operating Expenses

129 M 215 M 167 M 62 M 35.8 M 22.7 M - - - - - - -

General and Administrative Expenses

42.1 M 59.9 M 47.1 M 17 M 6.23 M 3.9 M - - - - - - -

All numbers in USD currency

Quarterly Income Statement Praxis Precision Medicines

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

18.9 M 18.8 M 13.9 M 8.79 M 9.04 M 4.65 M 3.54 M 49.4 M 45.8 M 45.5 M 45.5 M 45.3 M 44.7 M 41.6 M 38.5 M 38.3 M 1.67 M 1.64 M 1.63 M 1.62 M 1.56 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-51.9 M -32.7 M -39.6 M - -24.6 M -34.3 M -37.5 M - -43.9 M -60.2 M -68.7 M -58.6 M -44.7 M -36.4 M -27.4 M -25.7 M -16.2 M -11.6 M -8.33 M - -10.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

302 K 357 K 431 K - 468 K 781 K 683 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-56.8 M -37.5 M -41.9 M - -25.5 M -35 M -38.1 M - -44.3 M -60.4 M -68.8 M - -44.8 M -36.5 M -27.4 M - -16.2 M -11.6 M -8.47 M - -10.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

4.92 M 4.81 M 2.33 M - 884 K 648 K 636 K - 345 K 200 K 132 K - 73 K 82 K 46 K - 1 K 5 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - -41.8 M - - - -38 M - -44 M -60.2 M -68.8 M - -44.7 M -36.4 M -27.4 M - -16.2 M -11.6 M -8.46 M - -10.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

57.1 M 37.8 M 42.3 M - 26 M 35.7 M 38.8 M - 44.3 M 60.4 M 68.8 M - 44.8 M 36.5 M 27.4 M - 16.2 M 11.6 M 8.47 M - 10.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

15.3 M 10.6 M 15.3 M - 8.72 M 10.1 M 13.3 M - 13.9 M 16.8 M 16.2 M - 11.6 M 10.8 M 9.49 M - 3.43 M 2.52 M 1.6 M - 1.31 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency